# Robocath and MicroPort finalize joint venture for robotic platform in China

Robocath and MicroPort, through its subsidiary MedBot, finalized a joint venture to commercialize Robocath's R-One robotic-assisted platform in China. Robocath holds 49% and MedBot 51% of the joint venture.

- Type: Acquisition
- Announced: 2020-11-02
- Where: China
- Status: completed
- Products: R-One robotic-assisted platform
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [MicroPort Scientific Corporation](https://endata.com/companies/20849.md) (partner)
- [Robocath](https://endata.com/companies/46844.md) (partner)
- [MedBot](https://endata.com/companies/50897.md) (partner)

## Sources

- [robocath.com](https://www.robocath.com/robocath-finalizes-creation-of-the-joint-venture-with-microport-through-its-medical-robotic-subsidiary-medbot/), 2020-11-02: "Robocath, a company that designs, develops and commercializes cardiovascular robotic systems for the treatment of vascular diseases, today announces creation of the joint venture with MicroPort Scientific Corporation ‘MicroPort’, through ‘MedBot’, its MicroPort MedBot (Shanghai) Co. Ltd subsidiary."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.